Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer
Clinical trial NCT00564876 · TERMINATED
Trial details
- NCT number
- NCT00564876
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-09-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.